News

Video

Lifestyle modifications for glaucoma with Yvonne Ou, MD

Yvonne Ou, MD, a professor of ophthalmology at the University of California San Francisco, spoke about lifestyle modifications for glaucoma at this year's Glaucoma 360 meeting.

Yvonne Ou, MD, a professor of ophthalmology at the University of California San Francisco, spoke about lifestyle modifications for glaucoma at this year's Glaucoma 360 meeting. She took the audience through understanding the topic from preclinical data to human patient data.

Ou discussed several areas, including exercise, supplementation with nicotinamide, diet, and yoga. She explained that moderate aerobic exercise like walking, running, or cycling can help lower eye pressure, while high weight workouts may increase it, though the impact on glaucoma progression is unclear. Regarding yoga, she noted that inverted postures can temporarily elevate eye pressure, but that eye pressure returns to normal when the participant resumes an upright position. The breathing and meditation aspects can also be beneficial.

She also touched on nicotinamide, saying initial animal studies showed promise for neuroprotection, but there have been some cases of drug-induced liver toxicity with high doses. Major medical societies now recommend against high-dose nicotinamide outside of clinical trials, especially for those with liver disease.

When asked about her impressions of this conference, Ou shared that she felt this meeting, which combines the New Horizons Forum and Glaucoma 360 CME program, is valuable for bringing together experts, researchers, and industry to collaborate and advance the field. She was encouraged by the progress being made in vision restoration and neuroprotection, even though IOP lowering remains the only current treatment for glaucoma. She expressed hope that in the coming decades, neuroprotection and neuroenhancement approaches will come to fruition.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
Sheng Lim, MD, FRCOphth, discusses the CONCEPT study, which compared standalone cataract surgery to cataract surgery with ECP, at the 2025 ASCRS Annual Meeting.
(Image credit: Ophthalmology Times) ASCRS 2025: Steven J. Dell, MD, reports 24-month outcomes for shape-changing IOL
Alex Hacopian, MD, discusses a presbyopia-correcting IOL at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
© 2025 MJH Life Sciences

All rights reserved.